ST
PBYI icon

Spot Trading’s Puma Biotechnology PBYI Stock Holding History

Spot Trading’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-9,521
Closed -$292K – 3230
2016
Q4 		$292K Buy
+9,521
New +$412K 0.01% 1712
2016
Q1 		– Sell
-1,245
Closed -$98K – 3820
2015
Q4 		$98K Buy
1,245
+115
+10% +$9.03K ﹤0.01% 2815
2015
Q3 		$85K Sell
1,130
-1,588
-58% -$150K ﹤0.01% 3113
2015
Q2 		$317K Buy
2,718
+2,478
+1,033% +$449K ﹤0.01% 2410
2015
Q1 		$57K Sell
240
-163
-40% -$34.8K ﹤0.01% 3271
2014
Q4 		$76K Buy
+403
New +$89.4K ﹤0.01% 3325
2014
Q3 		– Sell
-3,936
Closed -$260K – 4626
2014
Q2 		$260K Buy
+3,936
New +$280K ﹤0.01% 3154

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Spot Trading's PBYI Position: Q1 2017 in Review

Spot Trading sold out of Puma Biotechnology (PBYI) in Q1 2017, closing a stake of 9,521 shares — an estimated $292K sold.

Spot Trading first reported a position in PBYI in Q2 2014 and held it in 7 quarters. The position peaked at $317K in Q2 2015. 136 funds tracked by Wall St. Rank hold PBYI as of Q1 2017.

  • Spot Trading reported no remaining Puma Biotechnology position as of Q1 2017 after selling out during the quarter.
  • Spot Trading sold 9,521 Puma Biotechnology shares in Q1 2017, an estimated $292K.
  • Spot Trading first reported a position in Puma Biotechnology in Q2 2014 and held it in 7 quarters.
  • Spot Trading's Puma Biotechnology position peaked at $317K in Q2 2015.
  • 136 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2017.

Based on Spot Trading's 13F filing for Q1 2017, filed 1 May 2017.